Alvaro Madrid Aris
Investigador
Grupo de investigación
Perfiles profesionales en las redes
Últimas publicaciones
- Planella-Cornudella M, Roca-Saladrigues N, Lopez-Baez V, Jatem-Escalante E, Sole-Mir E, Gomez-Arbones X, Alvaro Madrid Aris and Segarra-Medrano A Lymphocytic expression and IL-2 levels in calcineurin inhibitor-resistant nephrotic syndrome due to focal segmental glomerulosclerosis: Implications for calcineurin inhibitor response. nefrologia . 46(1): 501402-501402.
- Dixon BP, Kavanagh D, Alvaro Madrid Aris, Adams B, Kang HG, Wang E, Garlo K, Ogawa M, Amancha P, Chakravarty S, Heyne N, Kim SH, Cataland S, Yoon SS, Miyakawa Y, Luque Y, Muff-Luett M, Tanaka K and Greenbaum LA Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials Kidney Medicine . 6(8): 100855-100855.
- Salvia, R, Rico, LG, Bradford, JA, Ward, MD, Olszowy, MW, Martinez, C, Alvaro Madrid Aris, Grifols, JR, Ancochea, A, Gomez-Munoz, L, Vives-Pi, M, Martinez-Caceres, E, Fernandez, MA, Sorigue, M and Petriz, J Fast-screening flow cytometry method for detecting nanoplastics in human peripheral blood MethodsX . 10: 102057-102057.
